Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Biosimilars market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Biosimilars are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Biosimilars market segmented into
Ankylosing Spondylitis
Tablets
Others

Based on the end-use, the global Biosimilars market classified into
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular

Based on geography, the global Biosimilars market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddy's Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics
Merck KGaA

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOSIMILARS INDUSTRY
2.1 Summary about Biosimilars Industry
2.2 Biosimilars Market Trends
2.2.1 Biosimilars Production & Consumption Trends
2.2.2 Biosimilars Demand Structure Trends
2.3 Biosimilars Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Injection
4.2.2 Tablets
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Ankylosing Spondylitis
4.3.2 Tumor
4.3.3 Rheumatoid Arthrtis
4.3.4 Cardiovascular
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Injection
5.2.2 Tablets
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Ankylosing Spondylitis
5.3.2 Tumor
5.3.3 Rheumatoid Arthrtis
5.3.4 Cardiovascular
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Injection
6.2.2 Tablets
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Ankylosing Spondylitis
6.3.2 Tumor
6.3.3 Rheumatoid Arthrtis
6.3.4 Cardiovascular
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Injection
7.2.2 Tablets
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Ankylosing Spondylitis
7.3.2 Tumor
7.3.3 Rheumatoid Arthrtis
7.3.4 Cardiovascular
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Injection
8.2.2 Tablets
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Ankylosing Spondylitis
8.3.2 Tumor
8.3.3 Rheumatoid Arthrtis
8.3.4 Cardiovascular
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Injection
9.2.2 Tablets
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Ankylosing Spondylitis
9.3.2 Tumor
9.3.3 Rheumatoid Arthrtis
9.3.4 Cardiovascular
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sandoz International
10.1.2 Hospira
10.1.3 Teva Pharmaceutical
10.1.4 Dr. Reddy's Laboratories
10.1.5 Biocon
10.1.6 Mylan
10.1.7 Amgen
10.1.8 Celltrion
10.1.9 Roche Diagnostics
10.1.10 Merck KGaA
10.2 Biosimilars Sales Date of Major Players (2017-2020e)
10.2.1 Sandoz International
10.2.2 Hospira
10.2.3 Teva Pharmaceutical
10.2.4 Dr. Reddy's Laboratories
10.2.5 Biocon
10.2.6 Mylan
10.2.7 Amgen
10.2.8 Celltrion
10.2.9 Roche Diagnostics
10.2.10 Merck KGaA
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Biosimilars Product Type Overview
2.Table Biosimilars Product Type Market Share List
3.Table Biosimilars Product Type of Major Players
4.Table Brief Introduction of Sandoz International
5.Table Brief Introduction of Hospira
6.Table Brief Introduction of Teva Pharmaceutical
7.Table Brief Introduction of Dr. Reddy's Laboratories
8.Table Brief Introduction of Biocon
9.Table Brief Introduction of Mylan
10.Table Brief Introduction of Amgen
11.Table Brief Introduction of Celltrion
12.Table Brief Introduction of Roche Diagnostics
13.Table Brief Introduction of Merck KGaA
14.Table Products & Services of Sandoz International
15.Table Products & Services of Hospira
16.Table Products & Services of Teva Pharmaceutical
17.Table Products & Services of Dr. Reddy's Laboratories
18.Table Products & Services of Biocon
19.Table Products & Services of Mylan
20.Table Products & Services of Amgen
21.Table Products & Services of Celltrion
22.Table Products & Services of Roche Diagnostics
23.Table Products & Services of Merck KGaA
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Biosimilars Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Biosimilars Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Biosimilars Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Biosimilars Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Biosimilars Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Biosimilars Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Biosimilars Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Biosimilars Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Biosimilars Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Biosimilars Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Biosimilars Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Rheumatoid Arthrtis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Cardiovascular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Rheumatoid Arthrtis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Cardiovascular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rheumatoid Arthrtis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Cardiovascular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rheumatoid Arthrtis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Cardiovascular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rheumatoid Arthrtis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Cardiovascular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
75.Figure Rheumatoid Arthrtis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Gr

Asia Pacific Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...

Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...

North America Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...

Global Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Region: Trend Forecast and Growth Opportunity...

Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...

Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...

Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity...

Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...

North America Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity...

North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, ...

Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Region: Trend Forecast and Growth Opportunity...

Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing cl...

Global Biosimilars & Follow-on-Biologics Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Biosimilars & Follow-on-Biologics Market: The report discusses everything a marketer requires before investing in the global Biosimilars & Follow-on-Biologics Market during the forecast period...

2023-2028 Global and Regional Biosimilars Industry Status and Prospects Professional Market Research Report Standard Version...

The global Biosimilars market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field ev...